PsyMed Ventures
Venture capitalActively deployingBerkeley · Pre-Seed–Series A · 13 people tracked
Also known as PSYMED VENTURES MANAGEMENT LLC
Find your way into PsyMed Ventures
5,311 people in our graph share verified history with the PsyMed Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
PsyMed Ventures backs founders using frontier technologies to transform the treatment of brain and mental health conditions. Its investment focus spans neurotech and brain-computer interfaces, human augmentation, artificial intelligence for early detection and diagnosis, precision neuroscience, novel therapeutic modalities (genetic, RNA, and cell-based interventions), holistic medicine, neurometabolism, digital health and therapeutics, and horizontal platforms and novel compounds. The firm seeks to align healing, responsibility, and profitability, supporting companies working to turn the mental and brain illness epidemic into a healthier future.
Source: firm website, verified Sep 15, 2026.
Team · 13 people
from the firm's website & curated & public directories
Founder mafia
The PsyMed Ventures mafia →6 people who came through PsyMed Ventures went on to found or lead other companies.
What they invest in
from 21 of 34 portfolio companiesBiotech ×16Digital Health ×13Healthtech ×11Mental Health ×8AI & Machine Learning ×7Deep Tech ×7Medical Devices ×6AgTech ×1
HQs:United States×9
Who they back
founder profiles across 14 portfolio companiesFounding team size:solo founder×52 founders×73 founders×14+ founders×1
Where their founders studiedfrom 16 founders with education data
Harvard University ×3University of Michigan ×2
What their founders studiedfrom 15 founders with field-of-study data
Life Sciences ×6Engineering ×3Chemistry ×2
Where their founders worked beforefrom 19 founders with career history
Columbia University in the City of New York ×2Gilgamesh Pharma ×2
Accelerator rootsportfolio companies that came through a program
Investments · 34 tracked
founders shown can be your intro pathBy year:2024 · 22021 · 52020 · 29 dated
Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.
BiotechDeep TechHealthtechMedical Devices
Stuart Milstein(Co-Founder)inJack O’Meara(Cofounder)in
Co-investorsage1BlueYard CapitalEntrepreneur FirstIaso VenturesUnruly CapitalAda Ventures+3 more
.jpeg){kind=logo}
Ancilia is a biotech company using CRISPR to create beneficial bacterial products, such as live biotherapeutics, that carry immunity against the viruses that destroy them.
BiotechDeep TechHealthtechNew York, US
Rodolphe Barrangou(Co-founder)inAlex(Co-founder)inDavi Paez-Espino(Co-founder)inAlexandra Sakatos(Executive Officer, Director)in
BoardDale Pfost(Director)VERA SCHROEDER(Director)in
Co-investorsDeep Science VenturesMetaplanetSafar PartnersSnatched VenturesSpacecadet Ventures
AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.
BiotechMedical DevicesMental Health
Christian AngermayerCosmo Feilding Mellen(Founder)inSrinivas Rao
Co-investorsFJ LabsIter InvestmentsLeafy TunnelNoeticRedbus VenturesWhat If Ventures
Bloom Science is a clinical-stage biotech company developing live biotherapeutic products that replicate the effects of the ketogenic diet through the gut-brain axis.
BiotechDeep TechDigital HealthSan Diego, US
Co-investorsJoyance PartnersSocial StartsApollo Health VenturesLeaps by Bayer
Bright Minds Biosciences develops selective serotonin receptor agonists (5-HT2A and 5-HT2C) without 5-HT2B activity, built on a proprietary chemistry platform.
BiotechDeep TechHealthtechNew York, US
Alan Kozikowski(Executive Officer, Director)inIan McDonaldRyan Cheung(Chief Financial Officer)JAN PEDERSEN(Chief Science Officer)Gideon Shapiro(Executive Officer)Revati Sheeniwas(Executive Officer)
Delix Therapeutics develops third-generation, non-hallucinogenic neuroplastogens for people with neurological conditions, using a discovery platform to identify novel compounds.
BiotechDigital HealthMedical Devices
Co-investorsArtis VenturesCasa Verde CapitalNoeticOMX VenturesRA CapitalVertical Venture Partners+6 more
Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.
BiotechDigital HealthMental Health
Dr. John Krystal(Co-founder & CEO)inDina Burkitbayeva(Co-founder)in
Co-investorsBeni Venture CapitalEvolution VC PartnersIter InvestmentsLongeVCManta Ray VenturesUnruly Capital+1 more
Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.
AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US
Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJONATHAN SPORN(Founder)inAndrew Kruegel, Ph.D.(Executive Officer)Jonathan Sporn, M.D.(President and Chief Executive Officer)in
Co-investorsAera VCFrontera Technology VenturesFrontier Path VCJames Beshara FundJLSMagnetic Ventures+9 more
Iris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles.
BiotechDeep TechHealthtech
Megan Matthews(Co-founder & President)
Co-investorsVenrockUCB Ventures
Jimini Health develops behavioral health solutions using AI and language models for clinically supervised patient care.
AI & Machine LearningDigital HealthMental Health
Bill Hudenko(Chief Clinical Officer)
Co-investorsCity LightLionBirdSCB 10XZetta Venture Partners
Journey Clinical provides ketamine-assisted psychotherapy (KAP) for depression, anxiety, and PTSD, partnering patients with licensed therapists and medical teams while coordinating with major insurance providers.
Digital HealthMedical DevicesMental Health
Jonathan Sabbagh(Co-founder & Executive Chairman of the Board)inMyriam Barthes(Co-founder & CEO)in
Co-investorsAble PartnersAlleyCorpCoalition OperatorsFifty YearsMantis CapitalPROOF+5 more
Maya Health (Naitur) builds compliance-focused AI automation for independent health and wellness practices, covering intake-to-EMR sync, follow-ups, lab result delivery, rating-scale scoring, and safety escalation.
AI & Machine LearningDigital HealthHealthtech
Co-investorsInnovating CapitalLeafy Tunnel
Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US
Dillan DiNardo(Founder/CEO)inTom Ray(Founder)in
BoardRand Hindi(Director)in
Co-investorsImmeasurableMetaplanetXEIA Venture PartnersY CombinatorDay One VenturesInitialized Capital+3 more
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)in
BoardJacob Robinson(Co-founder & CEO)in
Co-investorsArboretum VenturesTMC Venture FundXEIA Venture PartnersCapital FactoryDivergent CapitalDolby Family Ventures+3 more
Neurode develops a wearable neurostimulation headband paired with a companion app that provides personalized insights and recommendations from psychologists, neuroscientists, and engineers.
AI & Machine LearningDigital HealthHardwareMedical DevicesMental Health
Damian(CTO)
Co-investorsStoic VC
Remepy develops "Hybrid Drugs" that combine pharmaceuticals with targeted digital interventions to deliver personalized and adaptive therapies for patients.
AI & Machine LearningBiotechDigital Health
Co-investors97212 Venturesfresh.fundIT-Farm CorporationNFXO.G. Venture PartnersSamsung Next+4 more
Reset Pharma is a CNS-focused pharmaceutical company developing psilocybin and related psychedelics for the treatment of mental illness in patients with life-threatening diseases.
BiotechDigital HealthHealthtechMental HealthNew York, US
John Andreadis(Executive Officer, Director)Jan-Anders Karlsson(Executive Officer, Director)Philip Taub(Director)Tim Schlidt(Director)
Co-investorsIter Investments
Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.
BiotechDeep TechHealthtech
Matthew Baggott(CEO)in
Co-investorsLeafy TunnelNoetic10X CapitalPalo SantoWefunder
Terran Biosciences is a biotech platform company developing therapeutics and technologies for neurological and psychiatric diseases, including late-stage drug candidates for schizophrenia, psychedelic and empathogen compounds, and an AI-based neuromelanin MRI analysis platform.
AI & Machine LearningBiotechDigital Health
Sam Clark(Chief Executive Officer)Dustin Tetzl(Chief Business Officer)
Co-investorsNoeticRed Beard Ventures
TRIPP provides immersive meditation and mindfulness experiences available through a mobile app and VR headset platform.
AgTechMental HealthWellness & FitnessVenice, US
Nanea Reeves(Executive Officer, Director)inZachary Norman(Executive Officer, Director)Kevin Keeland(Executive Officer)
BoardTim Chang(Director)
Co-investorsBeni Venture CapitalBitkraft Esports VenturesGrit Capital PartnersHartmann CapitalIter InvestmentsMayfield Fund+4 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AnciliaATAI Life SciencesBexson BiomedicalHumans AnonymousMaya HealthMindstatePODCASTSanmaiSculpta BioStealth BiotechStealth HealthcareStealth MarketplaceStealth Neurotech
Portfolio news
latest coverage across their companies
Gilgamesh Pharmaceuticals · wmbdradio.com · Jul 16, 2026
Beckley Psytech · wmbdradio.com · Jul 16, 2026
Tripp · armenpress.am · Jul 15, 2026
Motif Neurotech · businesswire.com · Dec 16, 2025
Delix · ucdavis.edu · Sep 10, 2025
Frequently asked questions
- How many investments has PsyMed Ventures made?
- PsyMed Ventures has 34 tracked investments, including 1 dated in the last 24 months.
- What stage does PsyMed Ventures invest at?
- PsyMed Ventures invests at the Pre-Seed, Seed, Series A stages.
- What sectors does PsyMed Ventures focus on?
- PsyMed Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Longevity, Medical Devices, Mental Health, Wellness & Fitness.
- Where is PsyMed Ventures located?
- PsyMed Ventures is headquartered in Berkeley, US.
- Who does PsyMed Ventures co-invest with?
- PsyMed Ventures most often shares deals with Noetic, Iter Investments, Spacecadet Ventures, among 68 tracked co-investors.
Media · Podcasts & interviews
featuring the teamInvesting In The Next Frontiers of Mental Health (Greg Kubin, PsyMed Ventures)
Scott Britton · Greg Kubin
Podcast E047: Dina Burkitbayeva of PsyMed Ventures
Female VC Lab · Dina Burkitbayeva
Images
Co-investors · 8
Mayfield is a venture capital firm that invests in early-stage consumer and marketplace companies, backing founders from inception through IPO.
What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.
RA Capital is a multi-stage investment firm focused on healthcare, life sciences, and planetary health, investing across public and private markets and creating new companies through its Raven incubation platform.
Artis Ventures is a venture capital firm focused on supporting founders reimagining the systems that sustain life, spanning from cellular biology to broader societal impact.
Baruch Future Ventures is a climate-tech focused family investment firm that backs entrepreneurs building companies in the climate economy.
Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.
Firms observed investing alongside PsyMed Ventures, from public investor directories. Shared companies are the overlap with PsyMed Ventures's recorded portfolio.
Similar investors
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.
LongeVC is a venture capital firm backing early-stage founders in biotech and longevity, aiming to bring breakthrough science and treatments to market.
Proton Enterprises is a venture development firm that partners with leaders by combining capital, time, and talent to build mission-driven businesses, while also investing broadly and backing emerging fund managers.
Pave Health Ventures is an early-stage investor and company builder focused on health, backing founders from the ideation stage across products, technology, and tech-enabled services.